In this piece, we explore reasons for creating a separate conversion factor within the MPFS, initially for advanced primary ...

Caristo Diagnostics, on a mission to transform the diagnosis and treatment of cardiovascular disease, announced today that ...

NeuroPace, Inc. (Nasdaq: NPCE), a medical technology company focused on transforming the lives of people living with epilepsy ...

New OPPS and PFS reimbursement rates give hospitals, imaging centers and physicians a unified path to use AI plaque analysis starting 2026 STAMFORD, Conn., Nov. 25, 2025 /PRNewswire/ -- Caristo ...

Soviet-style price controls have resulted in shortages in the supply of physician services. Fortunately, there are a number ...

Company reaffirms its commitment to patient access, clinical excellence, and responsible reimbursement reform under the new CMS framework. MISSOULA, MT / ACCESS Newswire / November 6, 2025 / Venture ...

LUND, Sweden - Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announced that the Centers for Medicare & Medicaid Services (CMS) has finalized a national payment ...

With its final 2026 Medicare Physician Fee Schedule, the agency is making it a little easier for healthcare organizations to develop and sustain remote patient monitoring (RPM) programs.

After issuing the Physician Fee Schedule (PFS) on October 31, the Centers for Medicare & Medicaid Services (CMS) has now published templates ...

US Medicare Sets Reimbursement Price For Promarkerd DKD Test. Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce that the U ...

Devyser today announced that the Centers for Medicare & Medicaid Services (CMS) has issued its final pricing determination for the company's PrenatalDetect RHD test (CPT 0536U) at $192. The non-invasi ...

The Centers for Medicare & Medicaid Services (“CMS”) recently finalized a Medicare payment rule with significant implications for life ...